Lovell R, Dunn JA, Begum G, et al: Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival. Br J Haematol 130: 542-548, 2005
Mathew P, Ahmann GJ, Witzig TE, et al: Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?. Br J Haematol 90: 459-461, 1995
Bharti AC, Shishodia S, Reuben JM, et al: Nuclear factorkappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 103: 3175-3184, 2004